 six-year experi comprehens approach treatment recurr childhood acut lymphoblast leukemia all-rez bfm relaps studi bfm group between april march children year age first relaps acut lymphoblast leukemia stratifi random multicentr trial all-rez bfm patient intens front-lin therapi stratif criteria time site relaps bone marrow BM relaps month front-lin therapi group BM month therapi group extramedullari relaps time group treatment cours polychemotherapi high- intermediate-dos methotrex infus idmtx infus mainten therapi patient daili oral thioguanin intraven IV mtx overal second complet remiss CR rate group probabl event-fre surviv ef year group hdmtx superior idmtx stop random risk factor analys earli relaps BM relaps month t-cell phenotyp independ predictor poor outcom incid central nervou system cn BM relaps reprophylaxi cn iv/intrathec IT mtx insuffici children bone marrow transplant second CR hla-compat sibl ef year outcom above-ment risk factor treatment regimen long-last second remiss third patient intens front-lin treatment